Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease

High Profile Cannabis Opens Its First Kentucky Dispensary in London

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

Support Egg Quality and Ovulation with Nature's Bounty® New Fertility Supplement*

Allergy & Asthma Network Convenes 29th Annual Capitol Hill Advocacy Event, Advancing Policy Priorities on Patient Access and Affordability

Altesa BioSciences Enrolls First Patient in Phase 2b CARDINAL Clinical Trial Evaluating Vapendavir as Transformational Treatment for Patients with COPD Impacted by Rhinovirus, the Leading Cause of Exacerbations

Harley-Davidson Delivers First Quarter Financial Results

Target Hospitality Announces First Quarter 2026 Earnings Release and Conference Call Schedule

Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years

FutureLife adopta una plataforma de fertilidad con IA integral, en colaboración con Alife Health

World Asthma Day Highlights Urgent Need for Education, Support and Advocacy to Improve the Lives of People with Asthma

Blueprint for a Lifetime: Hill's 'World of the Kitten' Report Supports Veterinary Teams & Pet Parents in Navigating the Critical First Year

Vision Coverage After Retirement (2026): VSP Vision Care Named Leading Option for Post-Employer Plans by Expert Consumers

Senhwa Biosciences Launches Global Study, Targeting Breakthrough in Hard-to-Treat Cancers with CX-5461 and Tislelizumab Combination

Hot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration

DIE EXPANSION UND DAS WACHSTUM VON ESTEVE IN DER EU SOWIE IN DEN USA BESCHLEUNIGEN DIE TRANSFORMATION ZU EINEM GLOBALEN GESUNDHEITSUNTERNEHMEN

New PSAs Highlight the Power of Connection to Combat Isolation

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

/C O R R E C T I O N -- Diakonos Oncology/

Sun Life U.S. announces continued support of the Gap Year Program at Northeastern University's Roux Institute in honor of recently retired company president, Dan Fishbein, M.D.

AltaPointe Health Now Providing Breakthrough Therapy for Treatment-Resistant Depression

Bedrock Bioscience Introduces Gazelle™ Chair, Offering a Breakthrough Non-Invasive Solution for Bladder Control and Pelvic Floor Strength

Building Healthier Communities: Our Health Our Wellness April 2026 Launch/Black Health Matters Foundation National Campaign for Health & Wellness

Longitude Rx Appoints Stacy Walton as Inaugural Chief Commercial Officer to Accelerate Growth and Market Expansion

AMERICAN SKIN ASSOCIATION LAUNCHES PODCAST SERIES, SKINSIGHT PODCAST: A PATIENT'S GUIDE, TO EXPAND PATIENT-CENTERED EDUCATION

Myocardial Solutions Launches MyoStrain® 6.1, Delivering Advanced Cardiac Diagnostic Capabilities and Workflow Innovations

National Children's Health and Wellness Complexes Being Built

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025